Moderna is developing a single vaccine against coronavirus and influenza

The new RNA vaccine combines the company’s current version of the coronavirus vaccine and the flu vaccine, which is also under development.

On Thursday, the American biotechnology company Moderna said that it is working on a vaccine that can protect against both the coronavirus and the flu.

“Today, we are announcing the first step in our new vaccine program [for respiratory diseases] – the development of a single-component vaccine that combines an additional dose against COVID – 19 and an additional dose against influenza,” Moderna CEO Stephane Bancel is quoted as saying in a published press release. The new RNA vaccine combines the company’s current version of the coronavirus vaccine and the flu vaccine, which is also under development.

The vaccine developed by Moderna is a special fat nanoparticle containing a fragment of coronavirus RNA. They can penetrate into human cells and cause them to produce many fragments of the SARS-COV-2 protein envelope, which leads to an immune reaction to the COVID-19 pathogen.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Watch more posts:
Author: Ivan Maltsev
The study of political and social problems of different countries of the world. Analysis of large companies on the world market. Observing world leaders in the political arena.
Function: Chief-Editor
Ivan Maltsev

Spelling error report

The following text will be sent to our editors: